We emined a mutant human apolipoprotein B (apoB) allele that causes hypobetalipoproteinemia and has a single cytosine deletion in exon 26. This fameshift mutation was associated with the synthesis of a truncated apoB protein of the predicted size; however, studies in human subjects and minigene expression studies in cultured cells indicated that the mutant allele also yielded a full-length apoB protein. The 1-base-pair deletion in the mutant apoB allele created a stretch of eight consecutive adenines. To understand the mechanism whereby the mutant apoB allele yielded a full-length apoB protein, the cDNA from cells transfected with the mutant apoB minigene expression vector was examined. Splicing of the mRNA was normal; however, 11% of the cDNA clones had an additional adenine within the stretch of eight adenines, yielding nine consecutive adenines. The insertion of the extra adenine, presumably during apoB gene transcription, is predicted to restore the correct apoB reading frame, thereby permitting the synthesis of a full-length apoB protein. In 1979, Steinberg et al. (1) characterized an unusual kindred (the H.J.B. kindred) with asymptomatic familial hypobetalipoproteinemia. Their studies suggested that H.J.B. and two of his siblings, who had extremely low levels of low density lipoprotein (LDL) cholesterol (<8 mg/dl), might be homozygotes for hypobetalipoproteinemia, whereas several other members of the kindred with moderately reduced LDLcholesterol levels (29-62 mg/dl) were postulated to be heterozygotes. In 1987, Young et al. (2, 3) reexamined the H.J.B. kindred and provided evidence for two different defective apolipoprotein B (apoB) alleles: one yielding a truncated apoB, apoB37, and a second yielding very low amounts of a full-length apoB100. They demonstrated that the three family members with extremely low LDL cholesterol levels were compound heterozygotes, whereas subjects with moderately low cholesterol levels were heterozygous for either the apoB37 allele or the allele yielding low amounts of apoB100. Subsequent studies revealed that the mutant allele yielding apoB37 had a 4-base-pair (bp) deletion that resulted in a premature stop codon and a truncated apoB protein containing 1728 amino acids (4).
In 1979, Steinberg et al. (1) characterized an unusual kindred (the H.J.B. kindred) with asymptomatic familial hypobetalipoproteinemia. Their studies suggested that H.J.B. and two of his siblings, who had extremely low levels of low density lipoprotein (LDL) cholesterol (<8 mg/dl), might be homozygotes for hypobetalipoproteinemia, whereas several other members of the kindred with moderately reduced LDLcholesterol levels mg/dl) were postulated to be heterozygotes. In 1987, Young et al. (2, 3) reexamined the H.J.B. kindred and provided evidence for two different defective apolipoprotein B (apoB) alleles: one yielding a truncated apoB, apoB37, and a second yielding very low amounts of a full-length apoB100. They demonstrated that the three family members with extremely low LDL cholesterol levels were compound heterozygotes, whereas subjects with moderately low cholesterol levels were heterozygous for either the apoB37 allele or the allele yielding low amounts of apoB100. Subsequent studies revealed that the mutant allele yielding apoB37 had a 4-base-pair (bp) deletion that resulted in a premature stop codon and a truncated apoB protein containing 1728 amino acids (4) .
The defect in the second mutant allele yielding very low levels of apoB100 is the subject of this report. The clue that led to the understanding of this allele was the recognition that H.J.B., as well as the other two compound heterozygotes, actually had four bona fide apoB species within their plasma lipoproteins: apoB37, apoB48, apoB100, and apoB86. In this study, we demonstrate that apoB86 and apoB100 are the products of a single mutant apoB allele, which we have designated the apoB86 allele. We show that the apoB86 allele has a 1-bp deletion in exon 26 of the apoB gene and that this frameshift mutation clearly results in the synthesis of apoB86. Furthermore, in cell culture expression studies, the apoB86 allele, which contains a premature stop codon, nevertheless results in the synthesis of a full-length apoB protein. deletion in the apoB86 allele creates a stretch of eight consecutive adenines. Addition of a single adenine within the eight consecutive adenines would be predicted to correct the altered reading frame, thereby resulting in the production of a full-length protein. We present data indicating that a significant percentage of the apoB cDNA clones from rat hepatoma cells transformed with an apoB construct containing the 1-bp deletion have nine consecutive adenines. We believe that the addition of an extra adenine during transcription restores the correct reading frame and accounts for the formation of apoB100 by the apoB86 allele.
MATERIALS AND METHODS
Human Subjects. The H.J.B. kindred was originally identified and characterized by Steinberg et al. (1) and further studied by Young et al. (2) (3) (4) (5) . Blood samples were collected from both affected and nonaffected family members. H.J.B., the proband, is one of the compound heterozygotes.
Characterization of the Plasma Lipoproteins. The lipoproteins were isolated from fresh plasma by ultracentrifugation (6) and analyzed by SDS/PAGE and Western blotting with apoB-specific antibodies (7-9) as described (10) . Rabbit antisera were developed against two new synthetic peptides: (i) apoB amino acids 3904-3920 and (ii) the 20 amino acids predicted from the 1-bp deletion (see Results).
Identification of the apoB86 Mutation. A 909-bp fragment of the apoB gene from exon 26 to exon 28 (apoB cDNA nucleotides 11, 173 , corresponding to amino acids 3856-3988) was enzymatically amplified (11) from the genomic DNA of a compound heterozygote, H.J.B., and an apoB86 heterozygote by using 30-mer oligonucleotide primers and Taq polymerase (Cetus) (11) . The DNA was cloned into M13 and sequenced (12) .
Amplification of Exon 4 of the apoB Gene. Exon 4 of the apoB gene contains an ApaLI restriction-site polymorphism (13) . (16) . pB33/86 and pB33/100 vectors were also constructed and were identical to pB18/86 and pB18/100 except that the 5' pB33 (15) segment coded for apoB amino acids 1-1480. Transfection of McA-RH7777 Cells. Prior to transfection, the segment of DNA flanking the apoB86 mutation was sequenced from each transfection vector to confirm the identity of the transfection plasmids. Stable transformants of McA-RH7777 cells were developed and the secreted proteins from these lines were analyzed as described (15) .
Preparation of cDNA and Enzymatic Amplification of cDNA. The cDNA from stable transformants was synthesized from RNA by using Rous-associated virus 2 (RAV-2) reverse transcriptase exactly according to the protocol in the cDNA Synthesis System Plus kit (Amersham). The segment ofapoB cDNA flanking the apoB86 mutation (cDNA nucleotides 11,774-12,173) was amplified with 30-mer oligonucleotide primers and Pyrococcus furiosus (Pfu) DNA polymerase (Stratagene) and was cloned into M13.
RESULTS
We examined three familial hypobetalipoproteinemia compound heterozygotes within a single kindred (1) who had four apoB species within their plasma lipoproteins: apoB100, apoB86, apoB48, and apoB37 (Fig. 1A) . The apoB37 allele contains a frameshift mutation in exon 26 (4) . In this study, we analyzed the apoB86 allele. Based on its migration in SDS/polyacrylamide gels, we estimated that apoB86 would contain -3900 amino acids. Western blots with peptidespecific antisera were consistent with this size estimate (Fig.  1B) ; furthermore, these studies indicated that the apoB100 in the plasma of a compound heterozygote contained the sequences encoded by exons 27-29 of the apoB gene. A 909-bp segment of the apoB gene spanning from the 3' end of exon 26 to exon 28 (corresponding to amino acids 3856-3988) from the DNA of a compound heterozygote and an apoB86 heterozygote was sequenced. For both subjects, half of the M13 clones had the normal apoB sequence and halflacked a single cytosine in exon 26 of the apoB gene (apoB cDNA nucleotide 11,840) ( Fig. 2 A and B ). This frameshift mutation is predicted to yield a 20-amino acid sequence (KKQIMLKQSWI-PHAAQPYSS) not found in the wild type, followed by a premature stop codon. An antiserum to a synthetic peptide containing this 20-amino acid sequence (frameshift peptide A Silver Stained 3877-3896) bound specifically to apoB86 but not to apoB100 (Fig. 1B) .
It was evident that the compound heterozygotes had two mutant apoB alleles, the apoB37 and apoB86 alleles, both of which contained frameshift mutations in exon 26. The origin of the apoB100 in their plasma was not clear. Two observations excluded the possibility that the apoB37 allele was responsible for the apoB100. First, apoB37 and apoB100 have different protein allotypes (3). Second, when the apoB37 mutation was inserted into an apoB53 cDNA expression vector and transfected into cells, only apoB37 (and no apoB53) was produced (15) .
We also considered the possibility that the apoB100 might be produced by a third mutant apoB allele producing very low amounts ofapoB100. [Normally, there is only one copy ofthe apoB gene per haploid genome (17) .] Pulsed-field agarose gel electrophoresis followed by Southern blot hybridization with 5' and 3' apoB gene probes revealed no evidence for a third apoB allele (data not shown). Fluorescent Proc. Natl. Acad. Sci. USA 89 (1992) 11433 (18) . Gene dosage studies, however, excluded the possibility of a third apoB allele. The apoB allotype-specific monoclonal antibody MB19 detects two apoB allotypes: MB191 and MB192. The protein allotypes of the compound heterozygotes' apoB100, apoB86, and apoB37 proteins are MB192, MB192, and MB191, respectively (3) . If the compound heterozygote truly had three apoB alleles, one would predict, based on the MB19 allotypes of apoB37, apoB86, and apoB100, that they would have two copies of an ApaLI(+) apoB allele and one copy of an ApaLI(-) apoB allele (13) . We enzymatically amplified exon 4 of the apoB gene with a 32P-labeled oligonucleotide and digested the amplified DNA with ApaLI. In repeated experiments, the fraction of the 32P-labeled exon 4 DNA from the compound heterozygotes that was cut with ApaLI was exactly the same as with normal human ApaLI heterozygotes and significantly less than with HepG2 cells, which have two ApaLI(+) alleles and one ApaLI(-) allele (14) (Fig. 3) . These studies demonstrated that the compound heterozygotes had only two apoB alleles, leading us to suspect that the apoB86 allele also yielded apoB100.
To examine the possibility that the apoB86 allele yielded both apoB100 and apoB86, we generated a "wild-type" apoB fusion protein expression vector (pB18/100) and a mutant expression vector containing the 1-bp deletion (Fig. 4A) A fusion protein vector was chosen because transfection efficiencies for a full-length apoB100 vector are very low. The location of the apoB86 mutation (which was contained in pB18/86 but not in pB18/100) is marked by a star. pB18 codes for amino acids 1-782; the exon 26-29 gene fragment codes for apoB amino acids 3636-4343. Two new amino acid residues, Pro and Gly, were introduced at the in-frame ligation. The full-length and truncated apoB fusion proteins are predicted to contain 1490 and 1044 amino acids, respectively. ApoB100 contains 4536 amino acids; apoB86, 3996 amino acids; apoB48, 2152 amino acids; and apoB37, 1728 amino acids. CMV, cytomegalovirus; hGH, human growth hormone; SV40, simian virus 40. (B) Western blot analysis of the apoB proteins secreted by the pB18/100 and pB18/86 stable transformants, using monoclonal antibody lD1 (epitope, apoB amino acids 474-539). The apoB proteins in the medium were concentrated by adsorption onto "Cab-O-Sil" (15) , electrophoresed on SDS/ 3-12% polyacrylamide gels, and transferred to nitrocellulose for West- dicted truncated apoB fusion protein as well as the full-length apoB fusion protein (Fig. 4B) thenticity of the full-length protein produced by the pB18/86-and pB18/100-transformed cell lines was confirmed by Western blots with apoB-specific monoclonal antibodies that bind to apoB amino acid sequences encoded by exon 29 (Fig. 4C) . A cell line stably transformed with pB33/86 also yielded a truncated and a full-length fusion protein (data not shown). When pB33/86 was expressed in COS-7 cells, the truncated protein was bound by the antiserum to frameshift peptide 3877-38% (data not shown).
We considered the possibility that alternative splicing was responsible for apoB100 production from the apoB86 allele. Activation of a cryptic splice site within exon 26 upstream from the apoB86 deletion could result in an in-frame deletion of the 3' end of exon 26, including the apoB86 frameshift mutation. Such an alternatively spliced mRNA would be expected to code for an apoB lacking the amino acids coded for by the 3' portion of exon 26. We were skeptical that this sort of alternative splicing was involved in the apoB86 mutation for several reasons. First, although one potential in-frame splice site (CCA/GUUUG) exists 10 bases upstream from the apoB86 mutation, a donor splice site with this sequence would be extremely unusual (19, 20) . Second, the frameshift mutation that we identified is not the type of mutation that has previously been associated with activation of a cryptic splice site (21) . Finally, this type of alternative splicing would be expected to shorten the full-length apoB by 30 or more amino acids. While the deletion of an =30-amino acid segment of apoB might be difficult to detect in a protein the size of apoB100, we would have observed a difference in the size of the full-length fusion proteins produced by the pB18/86 and pB18/100 cell lines,t and this was not the case (Fig. 4 B and C) . To evaluate the possibility of alternative splicing, however, we examined the cDNA of the pB18/86-transformed cells by amplifying the cDNA flanking the apoB86 mutation. Only the expected-size DNA band consistent with normal mRNA splicing (and no smaller product, such as would occur with the use of an alternative donor splice site in exon 26) was observed (Fig. 5A) .
To confirm the fidelity of exon 26-intron 26 splicing and to evaluate the apoB86 mutation further, a 399-bp cDNA fragment flanking the apoB86 mutation was amplified from the cDNA of a pB18/86 transformant with Pfu and cloned into M13. Most ofthe M13 cDNA clones had the mutant sequence of 8 consecutive adenines (Fig. 5B ). However, 11% had an additional adenine, resulting in 9 consecutive adenines (Figs. 2C and 5B), and 2% had 10 consecutive adenines (Figs. 2D and 5B). The exon 26-exon 27 splice junction was normal in all M13 clones. In the same experiment and using the same oligonucleotide primers, the 909-bp DNA fragment spanning from exon 26 to exon 29 was amplified from the genomic DNA ofthe same pB18/86 transformant and cloned into M13; 100 of 100 genomic M13 clones had 8 consecutive adenines (Fig. SB) (1992) 11435 teinemia that was originally identified and studied by Steinberg et al. (1) . This mutant apoB allele, the apoB86 allele, has a 1-bp deletion in exon 26 and is associated with the synthesis of the predicted truncated apoB, apoB86, and a full-length apoB100. The apoB100 is of normal length and is bound by many apoB-specific antibodies, including those specific for sequences in exons 27-29 (Fig. 1B) . We generated a minigene fusion construct containing the 1-bp deletion (pB18/86) and transfected it into rat hepatoma cells. We analyzed nine cell lines stably transformed with pB18/86; each of them synthesized and secreted both a truncated and a full-length apoB fusion protein (Fig. 4B) . The full-length apoB fusion protein was identical in size to the protein produced by the pB18/ 100-transformed cell lines, and it reacted with three different monoclonal antibodies with epitopes within exon 29 (Fig.  4C) . The cell culture findings argue strongly against the possibility that the apoB100 in the lipoproteins of the compound heterozygotes might be the result of somatic mosaicism (22, 23) or result from somatic recombination between the apoB37 and apoB86 alleles (24, 25) .
We found that 11% of the M13 clones from the pB18/86-transformed cells had an extra adenine within the stretch of eight consecutive adenines created by the single cytosine deletion. It seems likely that the insertion of the extra adenine occurs during transcription of the apoB86 allele. Wagner et al. (26) have shown that Escherichia coli RNA polymerase can add one or more adenines within long stretches of adenines, but this phenomenon has not been reported for mammalian RNA polymerase. Wagner et al. found that transcriptional insertion of an extra adenine within a long stretch of adenines corrected a -1 frameshift upstream from the lacZ gene, permitting substantial 8-galactosidase synthesis. We believe that the synthesis of the full-length apoB fusion protein in the pB18/86 stable transformants and the synthesis of apoB100 in the compound heterozygotes are probably due to an identical phenomenon. More studies will be required to determine whether this phenomenon is a general one or unique to this site in the apoB gene.
The fact that none of 100 M13 genomic apoB clones contained nine consecutive adenines argues strongly against the proposition that the cDNA findings might be an artifact resulting from enzymatic amplification of DNA or M13 cloning in E. coli. Although our studies did not directly examine the fidelity of the polymerases used in cDNA synthesis, several considerations argue against an artifact by a laboratory polymerase. Of the two polymerases involved in cDNA synthesis, the Klenow fragment of E. coli DNA polymerase I and reverse transcriptase, the latter is the more likely suspect in a question of enzyme infidelity (27) . Takeuchi et al. (28) compared the fidelity of reverse transcriptases from five different viruses [RAV-2, Moloney murine leukemia virus, human immunodeficiency virus type 1 (HIV-1), avian myelobastosis virus, and the HTLV-IIIB and GUN-1 isolates of HIV-1] on a poly(A) template and found that the reverse transcriptase used in our studies (RAV-2) had the highest level of fidelity (misincorporation rates ranging from 1/152,000 to 1/72,400 nucleotides). The random addition or deletion of nucleotides is not a frequent phenomenon with RAV-2 reverse transcriptase. In examining 250-300 bp of 100 cDNA M13 clones from Pfu-amplified DNA and 97 cDNA M13 clones from Taq-amplified cDNA, we found no nucleotide insertions or deletions, except within the stretch of 8 consecutive adenines. More significantly, Wagner et al. (26) have reported evidence that the closely related reverse transcriptase of avian myeloblastosis virus does not add or delete nucleotides along a stretch of 11 consecutive adenines (26) .
Another potential mechanism for reading-frame restoration in the apoB86 allele would be ribosomal frameshifting in the -1 direction at the site of the 1-bp deletion. The sequence A-AAA-AAG, which is created by the mutation, is a site for high-frequency ribosomal frameshifting in the -1 direction in E. coli (29) (30) (31) . However, this sequence is associated with extremely low or nonexistent levels of frameshifting in mammalian systems (32, 33) . Also, a stable mRNA stem-loop structure can almost always be identified immediately downstream from bacterial and retroviral ribosomal frameshifting sites (33, 34) , and no downstream stem-loop was identified in the apoB86 allele.
